Skip to main content
SpringerLink
Log in

Blood

  • Chapter
  • First Online:
Regenerative Medicine - from Protocol to Patient

  • 638 Accesses

Abstract

The transplantation of stem cells from the bone marrow, peripheral blood or cord blood has become a clinical procedure since the 1980s and is now annually performed in 10,000 of patients in the autologous and allogeneic setting world-wide. Refinement of human leukocyte antigen typing as well as recent advances in immunosuppression, anti-infective prophylaxis and therapy as well in supportive care have much improved the outcome of patients with leukemia and lymphoma, aplastic anemia, as well as hereditary diseases of the hematopoietic system. This is still an experimental therapy and patient subgroups that profit most from hematopoietic stem cell transplantation need to be defined. Consideration and classification of co-morbidity indices as well as cytogenetic risk factors are pivotal for making decisions on transplantation modalities. Modern conditioning regimens allow balancing of allo-effects against malignant cells versus normal tissue even in elderly patients. Recent innovations in cellular therapy combine allogeneic stem cell transplantation with genetically engineered or specifically selected T cells and potentially natural killer (NK) cells. Depletion of regulatory T cells and vaccination after allogeneic stem cell transplantation constitute further approaches to improve the long-term outcome of transplanted patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447–458

    Article  CAS  PubMed  Google Scholar 

  • Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U (2015) Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant 21(4):604–611

    Article  CAS  PubMed  Google Scholar 

  • Amrolia PJ, Almeida A, Davies SC, Roberts IA (2003a) Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach. BrJ Haematol 120:737–743

    Article  Google Scholar 

  • Amrolia PJ, Almeida A, Halsey C, Roberts IA, Davies SC (2003b) Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options. Br J Haematol 120:725–736

    Article  PubMed  Google Scholar 

  • Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560

    Article  PubMed  Google Scholar 

  • Arachchillage DR, Dalley CD, Reilly JT, Wilson G, Collins N, Snowden JA (2010) Long-term dual donor derived hematopoietic reconstitution following double unrelated cord blood transplantation – single unit dominance is not always the case. Br J Haematol 149:298–299

    Google Scholar 

  • Bacigalupo A, Passweg J (2009) Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin N Am 23:159–170

    Article  Google Scholar 

  • Barker JN, Scaradavou A, Stevens CE (2010) Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 115:1843–1849

    Google Scholar 

  • Barnes DW, Loutin JF (1953) Protective effects of implants of splenic tissue. Proc R Soc Med 46:251–252

    CAS  PubMed  Google Scholar 

  • Beelen DW, Gromke T, Trenschel R, Hilgendorf I, Wolff D, Elmaagacli A, Freund M, Casper J (2008) Treosulfan compared to total body irradiation-based preparative regimens before allogeneic stem cell transplantation for acute myeloid leukemia: a retrospective long-term study. ASH Annual Meeting Abstracts 112(11), #2149. 16-11-2008

    Google Scholar 

  • Bhatia M, Walters MC (2008) Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41:109–117

    Article  CAS  PubMed  Google Scholar 

  • Bhattacharya D, Czechowicz A, Ooi AG, Rossi DJ, Bryder D, Weissman IL (2009) Niche recycling through division-independent egress of hematopoietic stem cells. J Exp Med 206:2837–2850

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bortin MM (1970) A compendium of reported human bone marrow transplants. Transplantation 9:571–587

    Article  CAS  PubMed  Google Scholar 

  • Bradley TR, Metcalf D (1966) The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 44:287–300

    Article  CAS  PubMed  Google Scholar 

  • Breems DA, Lowenberg B (2007) Acute myeloid leukemia and the position of autologous stem cell transplantation. Semin Hematol 44:259–266

    Article  PubMed  Google Scholar 

  • Brown JR (2011) The treatment of relapsed refractory chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Prog 110–118

    Google Scholar 

  • Carpenter RO, Evbuomwan MO, Pittaluga S et al (2013) B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res 19:2048–2060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Casalegno-Garduno R, Schmitt A, Yao J, Wang X, Xu X, Freund M, Schmitt M (2010) Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunol Immunother 59:195–202

    Article  CAS  PubMed  Google Scholar 

  • Casper J, Wolff D, Knauf W, Blau IW, Ruutu T, Volin L, Wandt H, Schäfer-Eckart K, Holowiecki J, Giebel S, Aschan J, Zander AR, Kröger N, Hilgendorf I, Baumgart J, Mylius HA, Pichlmeier U, Freund M (2010) Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning. J Clin Oncol 28:3344–3351

    Article  CAS  PubMed  Google Scholar 

  • Casucci M, Nicolis di Robilant B, Falcone L et al (2013) CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood 122:3461–3472

    Article  CAS  PubMed  Google Scholar 

  • Chan WW, Wise SC, Kaufman MD, Ahn YM, Ensinger CL, Haack T, Hood MM, Jones J, Lord JW, Lu WP, Miller D, Patt WC, Smith BD, Petillo PA, Rutkoski TJ, Telikepalli H, Vogeti L, Yao T, Chun L, Clark R, Evangelista P, Gavrilescu LC, Lazarides K, Zaleskas VM, Stewart LJ, Van Etten RA, Flynn DL (2011) Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036. Cancer Cell 19:556–568

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chu J, He S, Deng Y et al (2014) Genetic modification of T cells redirected towards CS1 enhances eradication of myeloma cells. Clin Cancer Res 20:3989–4000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Colvin GA, Lambert JF, Abedi M, Hsieh CC, Carlson JE, Stewart FM, Quesenberry PJ (2004) Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology. Leukemia 18:575–583

    Article  CAS  PubMed  Google Scholar 

  • Couzin-Frankel J (2013) Breakthrough of the year 2013. Cancer immunotherapy. Science 342:1432–1433

    Article  CAS  PubMed  Google Scholar 

  • Czechowicz A, Kraft D, Weissman IL, Bhattacharya D (2007) Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318:1296–1299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deininger MW (2008) Milestones and monitoring in patients with CML treated with imatinib. Hematol Am Soc Hematol Educ Prog 419–426

    Google Scholar 

  • den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, Reinhardus C, Shabanowitz J, Offringa R, Hunt DF, Engelhard VH, Goulmy E (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054–1057

    Article  Google Scholar 

  • Dohner H, Gaidzik VI (2011) Impact of genetic features on treatment decisions in AML. Hematol Am Soc Hematol Educ Prog:36–42

    Google Scholar 

  • Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Lowenberg B, Bloomfield CD (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474

    Article  PubMed  Google Scholar 

  • Dreger P (2009) Allotransplantation for chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Prog 602–609

    Google Scholar 

  • Dreger P, Corradini P, Kimby E, Michallet M, Milligan D, Schetelig J, Wiktor-Jedrzejczak W, Niederwieser D, Hallek M, Montserrat E (2007) Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia 21:12–17

    Article  CAS  PubMed  Google Scholar 

  • Dreger P, Schetelig J, Andersen N, Corradini P, van Gelder M, Gribben J, Kimby E, Michallet M, Moreno C, Stilgenbauer S, Montserrat E, European Research Initiative on CLL (ERIC), European Society for Blood and Marrow Transplantation (EBMT) (2014) Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? Blood 124:3841–3849

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ema H, Takano H, Sudo K, Nakauchi H (2000) In vitro self-renewal division of hematopoietic stem cells. J Exp Med 192:1281–1288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ford CE, Hammerton JL, Barnes DW, Loutin JF (1956) Cytological identification of radiation-chimaeras. Nature 177:452–454

    Article  CAS  PubMed  Google Scholar 

  • Giannopoulos K, Mertens D, Buhler A, Barth TF, Idler I, Moller P, Krober A, Greiner J, Chocholska S, Dmoszynska A, Rolinski J, Dohner H, Stilgenbauer S, Schmitt M (2009) The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia. Leukemia 23:519–527

    Article  CAS  PubMed  Google Scholar 

  • Ginsburg H, Sachs L (1963) Formation of pure suspension of mast cells in tissue culture by differentiation of lymphoid cells from the mouse thymus. J Natl Cancer Inst 31:1–40

    CAS  PubMed  Google Scholar 

  • Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295–304

    Article  CAS  PubMed  Google Scholar 

  • Gokbuget N, Hoelzer D (2009) Treatment of adult acute lymphoblastic leukemia. Semin Hematol 46:64–75

    Article  PubMed  Google Scholar 

  • Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, Burnett AK, Chopra R, Wiernik PH, Foroni L, Paietta E, Litzow MR, Marks DI, Durrant J, McMillan A, Franklin IM, Luger S, Ciobanu N, Rowe JM (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 111:1827–1833

    Article  CAS  PubMed  Google Scholar 

  • Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, Van Rood JJ (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334:281–285

    Article  CAS  PubMed  Google Scholar 

  • Gross G, Waks T, Eshhar Z (1989) Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci U S A 86:10024–10028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J, Ramee JF, Arakelyan N, Thyss A, Molucon-Chabrot C, Delepine R, Milpied N, Colombat P, Deconinck E (2009) High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood 113:995–1001

    Article  CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint BG, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, MacIntyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419

    Article  CAS  PubMed  Google Scholar 

  • Harrison DE, Astle CM (1982) Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med 156:1767–1779

    Article  CAS  PubMed  Google Scholar 

  • Hoseini SS, Hapke M, Herbst J, Wedekind D, Baumann R, Heinz N, Schiedlmeier B, Vignali DA, van den Brink MR, Schambach A, Blazar BR, Sauer MG (2015) Inducible T-cell receptor expression in precursor T cells for leukemia control. Leukemia. doi:10.1038/leu.2015.20

    PubMed  Google Scholar 

  • Kalos M, Rapoport AP, Stadtmauer EA, Vogl DT, Weiss BM, Binder-Scholl GK, Smethurst DP, Kulikovskaya I, Gupta M, Macatee TL, Finklestein JM, Brewer JE et al (2012) Prolonged T cell persistence, homing to marrow and selective targeting of antigen positive tumor in multiple myeloma patients following adoptive transfer of T cells genetically engineered to express an affinity-enhanced T cell receptor against the cancer testis antigens NY-ESO-1 and lage-1. ASH Ann Meet Abstr 120:755

    Google Scholar 

  • Kanakry CG, O’Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, Mielcarek M, Champlin RE, Jones RJ, Thall PF, Andersson BS, Luznik L (2014) Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning. J Clin Oncol 32:3497–3505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kershaw MH, Westwood JA, Darcy PK (2013) Gene-engineered T cells for cancer therapy. Nat Rev Cancer 13:525–541

    Article  CAS  PubMed  Google Scholar 

  • Klein J, Sato A (2000a) The HLA system. First of two parts. N Engl J Med 343:702–709

    Article  CAS  PubMed  Google Scholar 

  • Klein J, Sato A (2000b) The HLA system. Second of two parts. N Engl J Med 343:782–786

    Article  CAS  PubMed  Google Scholar 

  • Kodera Y (2008) The Japan marrow donor program, the Japan cord blood bank network and the Asia blood and marrow transplant registry. Bone Marrow Transplant 42(Suppl 1):S6–S6

    Article  PubMed  Google Scholar 

  • Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H, Appelbaum FR, Dohner H, Antin JH, Soiffer RJ, Cutler C (2009) Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301:2349–2361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, Fry TJ, Orentas R, Sabatino M, Shah NN, Steinberg SM, Stroncek D, Tschernia N, Yuan C, Zhang H, Zhang L, Rosenberg SA, Wayne AS, Mackall CL (2015) T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet 385(9967):517–528

    Article  CAS  PubMed  Google Scholar 

  • Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk KM, Verdonck LF, Beck J, Dohner H, Gratwohl A, Pabst T, Verhoef G (2009) High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 361:1235–1248

    Article  PubMed  Google Scholar 

  • Luznik L, O’Donnell PV, Fuchs EJ (2012) Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol 39:683–693

    Article  CAS  PubMed  Google Scholar 

  • Mielke S, McIver ZA, Shenoy A, Fellowes V, Khuu H, Stroncek DF, Leitman SF, Childs R, Battiwalla M, Koklanaris E, Haggerty J, Savani BN, Rezvani K, Barrett AJ (2011) Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. Biol Blood Marrow Transplant 17:1855–1861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mihara K, Bhattacharyya J, Kitanaka A et al (2012) T cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells. Leukemia 26:365–367

    Article  CAS  PubMed  Google Scholar 

  • Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH (1995) BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma. J Clin Oncol 13:588–595

    CAS  PubMed  Google Scholar 

  • Moretta A, Pende D, Locatelli F, Moretta L (2009) Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. Clin Exp Immunol 157:325–331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrison SJ, Prowse KR, Ho P, Weissman IL (1996) Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207–216

    Article  CAS  PubMed  Google Scholar 

  • Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E (1999) Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 5:839–842

    Article  CAS  PubMed  Google Scholar 

  • Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, Mahlaoui N, Debre M, Casanova JL, Dal Cortivo L, Madec Y, Hacein-Bey-Abina S, de Saint BG, de Villartay JP, Blanche S, Cavazzana-Calvo M, Fischer A (2009) Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 113:4114–4124

    Article  CAS  PubMed  Google Scholar 

  • Nowell PC, Cole LJ, Habermeyer JG, Roan PL (1956) Growth and continued function of rat marrow cells in x-radiated mice. Cancer Res 16:258–261

    CAS  PubMed  Google Scholar 

  • Papayannopoulou T, Scadden DT (2008) Stem-cell ecology and stem cells in motion. Blood 111:3923–3930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peinert S, Prince HM, Guru PM et al (2010) Genemodified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. Gene Ther 17:678–686

    Article  CAS  PubMed  Google Scholar 

  • Piccin A, McCann S, Socie G, Oneto R, Bacigalupo A, Locasciulli A, Marsh J, Schrezenmeier H, Tichelli A, Hand E et al (2010) Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT. Bone Marrow Transplant 45:1008–1013

    Article  CAS  PubMed  Google Scholar 

  • Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Ann Rev Immunol 11:213–244:213–244

    Google Scholar 

  • Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Fang HB, Cai L, Janofsky S, Chew A, Storek J, Akpek G, Badros A, Yanovich S, Tan MT, Veloso E, Pasetti MF, Cross A, Philip S, Murphy H, Bhagat R, Zheng Z, Milliron T, Cotte J, Cannon A, Levine BL, Vonderheide RH, June CH (2011) Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma. Blood 117:788–797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rezvani K (2011) Posttransplantation Vaccination: Concepts today and on the horizon. Hematol Am Soc Hematol Educ Prog:299–304

    Google Scholar 

  • Ringhoffer M, Harsdorf S, Schmitt M, Wiesneth M, Zenz T, Stilgenbauer S, Greiner J, Dohner K, Marx M, Dohner H, Bunjes D (2007) Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse. Br J Haematol 136:127–130

    Article  PubMed  Google Scholar 

  • Saussele S, Lauseker M, Gratwohl A, Beelen DW, Bunjes D, Schwerdtfeger R, Kolb HJ, Ho AD, Falge C, Holler E et al (2010) Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. Blood 115:1880–1885

    Google Scholar 

  • Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weisinger E, Bunjes D, von Harsdorf S, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb H-J (2006) Longterm survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 108:1092–1099

    Article  CAS  PubMed  Google Scholar 

  • Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, Volin L, Gurman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V (2007) Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 25:4938–4945

    Article  CAS  PubMed  Google Scholar 

  • Schmitt M, Schmitt A, Rojewski M, Chen J, Götz M, Heyduk M, Giannopoulos K, Ritter G, Gnjatic S, Guillaume P, Ringhoffer M, Schlenk R, Liebisch P, Bunjes D, Shiku H, Döhner H, Greiner J (2008) RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses. Blood 111:1357–1365

    Article  CAS  PubMed  Google Scholar 

  • Schmitt A, Tonn T, Busch D, Grigoleit G, Einsele H, Odenthal M, Germeroth L, Ringhoffer M, Ringhoffer S, Wiesneth M, Detlef M, Mertens T, Rojewski M, Marx M, Harsdorf S, Döhner H, Seifried E, Bunjes D, Schmitt M (2010) Adoptive transfer and selective reconstitution of streptamer-selected CMV-specific CD8+ T cells leads to virus clearance in patients after allo-PBSCT. Transfusion 51:591–599

    Article  PubMed  Google Scholar 

  • Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110:1397–1400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schuberth PC, Jakka G, Jensen SM, Wadle A, Gautschi F, Haley D, Haile S, Mischo A, Held G, Thiel M, Tinguely M, Bifulco CB et al (2013) Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Ther 20:386–395

    Article  CAS  PubMed  Google Scholar 

  • Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7:340–352

    Article  CAS  PubMed  Google Scholar 

  • Sodani P, Isgro A, Gaziev J, Polchi P, Paciaroni K, Marziali M, Simone MD, Roveda A, Montuoro A, Alfieri C et al (2010) Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood 115:1296–302

    Google Scholar 

  • Stadtmauer EA, Vogl DT, Weiss BM, Binder-Scholl GK, Smethurst DP, Finklestein J, Kulikovskaya I, Gupta M, Brewer JE, Bennett AD, Gerry AB, Pumphrey NJ et al (2013) Engineered T-cells expressing an HLA-restricted affinity-enhanced TCR in advanced multiple myeloma patients post auto-SCT engraft and are associated with encouraging post auto-SCT responses. Blood 122:766

    Google Scholar 

  • Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K (1994) Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941–949

    CAS  PubMed  Google Scholar 

  • Surh CD, Sprent J (2005) Regulation of mature T cell homeostasis. Semin Immunol 17:183–190

    Article  CAS  PubMed  Google Scholar 

  • The EBMT-ESH handbook – haematopoietic stem cell transplantation. 5th edn. Forum Service Editore, Genoa (2008)

    Google Scholar 

  • Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491–496

    Article  CAS  PubMed  Google Scholar 

  • Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation. N Engl J Med 292:832–843, 895–902

    Google Scholar 

  • Van Tedeloo VF, Van de Velde V, Van Driesche A et al (2010) Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A 107:13824–13829

    Article  Google Scholar 

  • Vanneman M, Dranoff G (2012) Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12:237–251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vos O, Davids JA, Weyzen WW, van Bekkum DW (1956) Evidence for the cellular hypothesis in radiation protection by bone marrow cells. Acta Physiol Pharmacol Neerl 4:482–486

    CAS  PubMed  Google Scholar 

  • Wang X, Schmitt A, Chen B, Xu X, Mani J, Linnebacher M, Freund M, Schmitt M (2010) Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions. Exp Hematol 38:1066–1073

    Article  CAS  PubMed  Google Scholar 

  • Yanada M, Matsuo K, Suzuki T, Naoe T (2006) Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer 106:2657–2663

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cellular Immunotherapy, University Clinic Heidelberg, Heidelberg, Germany

    Michael Schmitt & Lei Wang

  2. Department of Internal Medicine III, University of Rostock, Rostock, Germany

    Mathias Freund

Authors
  1. Michael Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathias Freund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Schmitt .

Editor information

Editors and Affiliations

  1. Department of Cardiac Surgery and Refere, University of Rostock, Rostock, Mecklenburg-Vorpomm., Germany

    Gustav Steinhoff

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schmitt, M., Wang, L., Freund, M. (2016). Blood. In: Steinhoff, G. (eds) Regenerative Medicine - from Protocol to Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-28386-9_1

Download citation

Publish with us

Policies and ethics

Search

Navigation